Citing No Clinical Data, FDA Approves Boosters For Children 12 And Up

As the new Omicron variant leads to record high cases of COVID-19, the Food and Drug Administration (FDA) has approved COVID-19 boosters for children between the ages of 12 and 15 for emergency authorized use based on “real-world” data from Israel. “Throughout the pandemic, as the virus that causes COVID-19 has continuously evolved, the need for the FDA to quickly adapt has meant using the best available science to make informed decisions with the health and safety of the American public in mind,” Acting FDA Commissioner Janet Woodcock said. “With the current wave of the omicron variant, it’s critical that

